A CBD-rich hemp extract is superior to CBD alone in reducing relapse to methamphetamine-seeking in rats (2026)

In preclinical models, the non-intoxicating cannabis component cannabidiol (CBD) reduces relapse to methamphetamine (Meth)-seeking and Meth-induced hyperactivity in rats. Cannabis products containing multiple cannabinoids ("full spectrum") may offer greater therapeutic potential than single cannabin